SynthesisFrontiers in nutrition2026
Clinical effects of probiotic supplementation on depressive symptom severity in adults with depressive disorders: a systematic review and meta-analysis.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Probiotic supplementation has been investigated as a potential adjunctive treatment for depressive disorders, but its clinical efficacy and safety remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of probiotics on depressive symptom severity, clinical response, remission, treatment discontinuation, and adverse events in adults with clinically diagnosed depressive disorders. Methods: This systematic review and meta-analysis was conducted in accordance with PRISMA guidelines. PubMed, Embase, Web of Science, and the Cochrane Library were searched from inception to May 8, 2026. Randomized controlled trials (RCTs) evaluating orally administered probiotics against placebo or another non-probiotic control were included. Continuous outcomes were summarized as standardized mean differences (SMDs) using Hedges' g, and dichotomous outcomes as risk ratios (RRs), with 95% confidence intervals (CIs). Random-effects models used restricted maximum likelihood estimation with Hartung-Knapp adjustment. Heterogeneity was assessed using Cochran's Q, I Results: Nine RCTs involving 460 participants were included. Probiotic supplementation was associated with a modest reduction in depressive symptom severity (SMD, -0.43; 95% CI, -0.73 to -0.12; I Conclusion: Probiotic supplementation may modestly reduce depressive symptom severity, particularly as an adjunct to established treatment. However, the prediction interval included the null, and evidence regarding clinical response, remission, and safety remained inconclusive. Larger, adequately powered RCTs with standardized clinically meaningful outcomes and strain-specific reporting are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.